UPDATED Apr 24, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
STX | UK£0.013 | -10.5% | -82.9% | UK£10.4m | n/a | PS1.7x | E89.2% | n/a | ||
DXRX | UK£1.03 | -1.0% | 2.0% | UK£87.0m | UK£1.67 | PE14497.6x | E59.5% | n/a | ||
INDV | UK£15.14 | -2.4% | 3.0% | UK£2.1b | UK£24.82 | PE1278.4x | E33.5% | 0% | ||
SAR | UK£0.30 | 48.8% | -74.2% | UK£32.6m | UK£1.76 | PB78.1x | E117.2% | n/a | ||
LLAI | UK£0.31 | 0% | -45.1% | UK£9.5m | UK£2.20 | PS257.5x | E88.7% | n/a | ||
GNS | UK£17.00 | -3.0% | -37.4% | UK£1.1b | UK£29.62 | PE33.4x | E26.0% | 1.9% | ||
AZN | UK£113.52 | 4.5% | -4.2% | UK£176.0b | UK£129.63 | PE36.8x | E16.3% | 2.0% | ||
APH | UK£0.35 | -4.4% | -41.5% | UK£189.1m | n/a | PS1.1x | E46.4% | 0% | ||
EAH | UK£0.94 | 0% | -20.0% | UK£63.7m | UK£1.85 | PB0.8x | E46.5% | 0% | ||
DPH | UK£38.66 | 0.2% | 32.4% | UK£4.4b | UK£37.59 | PS5.8x | E62.5% | 0% | ||
TRX | UK£0.61 | 2.8% | 1.7% | UK£43.3m | UK£1.20 | PS1.8x | E133.0% | n/a | ||
GSK | UK£16.36 | 2.9% | 13.4% | UK£66.8b | UK£20.06 | PE13.6x | E9.3% | 3.5% | ||
HIK | UK£18.13 | 2.2% | 2.6% | UK£4.0b | UK£23.01 | PE26.4x | E18.1% | 3.2% | ||
HCM | UK£2.96 | 9.6% | 23.8% | UK£2.5b | UK£4.28 | PE31.3x | E18.7% | n/a | ||
ERGO | UK£13.46 | 0.1% | 3.5% | UK£701.1m | UK£14.34 | PE46.7x | E14.2% | n/a | ||
BVX | UK£0.12 | 2.2% | -23.3% | UK£9.5m | n/a | PB3.4x | E63.8% | n/a | ||
NIOX | UK£0.67 | 3.4% | 48.3% | UK£284.9m | n/a | PE30x | E16.9% | 1.5% |